Resilient Operations and Dynamic Innovations: SSE-Listed Companies Post Both Quantity and Quality Growth in the First Three Quarters
By He Xinyi, Shanghai Securities News
On November 1, the Shanghai Stock Exchange (SSE) released its overview of SSE-listed companies' reports over the first three quarters of 2026.In the timeframe, 2,317 companies generated combined operating revenue of RMB 39.07 trillion, up 3.8% year on year, and net profit of RMB 4.01 trillion, up 6.0%.Some 80% of the companies turned a profit, while 60% reported year-on-year growth in net profit. A total of 806 companies recorded growth in both revenue and profit, and 441 posted profit growth of more than 50%.
Solid Operating Performance
Blue chip companies continued to play a prominent stabilizing role. SSE 50 companies generated operating revenue of RMB 11.84 trillion, up 4.9% year on year, and net profit of RMB 1.73 trillion, up 9.8%. These growth rates were 1.1 and 3.8 percentage points higher, respectively, than those of the SSE market as a whole. SSE 180 constituents posted operating revenue of RMB 24.15 trillion, up 4.7%, and net profit of RMB 2.98 trillion, up 6.9%, with both growth rates outstripping the SSE market by 0.9 percentage points. On the STAR Market, excluding three red chip companies, including Semiconductor Manufacturing International Corporation (SMIC), that had yet to release their third-quarter reports, the 614 companies that had disclosed results reported combined operating revenue of RMB 1.51 trillion, up 41.9% year on year, and net profit of RMB 223.52 billion, up 474.6%.In the third quarter alone, revenue increased 44.8% year on year and net profit surged 455.3%. A total of 277 companies recorded quarter-on-quarter growth in net profit.
A range of operating indicators also improved in tandem.Real-economy companies generated net cash flow from operating activities of RMB 2.83 trillion, up 18.3% year on year and equivalent to 1.5 times their net profit. Gross margins rose by 1.4 percentage points, while the median gross margin of STAR Market companies remained high at 36.7%.
Ever-Increasing R&D Investment
Real-economy companies funneled RMB 678.111 billion into R&D, up 4.8% year on year, while the median R&D-to-revenue ratio of STAR Market companies hit 12.6%.Companies across the artificial intelligence industry chain are reaping business results at a faster pace. CXMT Corporation made a breakthrough in its 4F2 DRAM architecture, with its share of the global market reaching double digits for the first time. Sugon and Hygon Information Technology helped bring China's first homegrown 100,000-GPU AI supercluster into operation. JCET's XDFOI platform has entered mass production. The biopharmaceutical sector also made great strides, with 15 innovative Class 1 drugs approved for marketing. Hengrui Pharmaceuticals, RemeGen, and other companies closed 12 business development (BD) licensing deals for overseas markets, with a potential aggregate transaction value topping USD 30.6 billion. XGIMI Tech's high-end smart projectors have ranked first globally in home projector shipments for three straight years, while Dongfang Electric achieved its first complete-set export of an F-class heavy-duty gas turbine.
Sustained Momentum in M&A, Dividend Payouts, Share Buybacks, and Stake Increases
The capacity of the six measures to facilitate M&A and restructuring has become increasingly evident. In the first nine months, listed companies announced 546 asset restructuring transactions, including 46 major asset restructurings, with a combined transaction value passing the RMB 500 billion mark. More than 250 share buyback plans were rolled out, with aggregate maximum buyback amounts surpassing RMB 72 billion, up 12% and 24%, respectively. Roughly 200 plans for stake increases by major shareholders were also disclosed, with aggregate maximum investment amounts exceeding RMB 29 billion. The maximum amounts under the buyback and stake-increase plans announced by companies including China Three Gorges Renewables, GigaDevice Semiconductor, and Hengrui Pharmaceuticals each topped RMB 2 billion. A total of 515 companies announced interim dividend distribution plans, with aggregate cash dividends exceeding RMB 693 billion, up 0.8% year on year. Of these, 71 companies declared dividend payouts of more than RMB 1 billion each. As of October 30, SSE 50 constituents had an average dividend yield of 3.6%, with eight companies surpassing 5%. The average dividend yield of SSE 180 constituents stood at 3.4%, with 28 companies above 5%. High-dividend-yield companies spanned multiple sectors, including banking and coal.